Patent ID: 7923208

Claim:
A method for detecting ovarian cancer, stomach cancer, uterine cancer, rectal cancer, lung cancer and esophageal cancer, comprising: incubating a polynucleotide comprising at least 14 contiguous nucleotides of SEQ ID NO:1 or the complement of SEQ ID NO:1 with a tissue or biological sample from a patient under conditions wherein the polynucleotide will hybridize to a complementary polynucleotide sequence; detecting hybridization of the polynucleotide in the tissue or biological sample; and comparing the level of hybridization of the polynucleotide in the tissue or biological sample from the patient to hybridization in a control tissue or biological sample, wherein an increase in hybridization in the tissue or biological sample from the patient, relative to the control tissue or biological sample, is indicative of a cancer involving epithelial tissue.